logo-loader

Willow Bioscience takes first major step towards development of pharmaceutical grade CBG

Published: 08:45 29 Jul 2020 EDT

Willow Bioscience (TSE: WLLW: OTCQX: CANSF) CEO Trevor Peters joined Steve Darling from Proactive Vancouver with news the company has hit a major milestone in their development. Peters talks about this significant step. Peters also talked about the company as a whole and what separates them from others in their sector.

Willow Bioscience announces unique collaboration with Enterin Inc

Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share news the company has announced they plan to collaborate with Enterin, which is a clinical stage biopharmaceutical company pioneering novel treatments that target neurodegenerative and metabolic disorders, to...

on 17/1/24